Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
15.62 USD | -8.79% | -8.20% | -49.92% |
06:04pm | Stifel Adjusts Price Target on ACADIA Pharmaceuticals to $21 From $26, Keeps Hold Rating | MT |
05-08 | Transcript : ACADIA Pharmaceuticals Inc., Q1 2024 Earnings Call, May 08, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-49.92% | 2.83B | |
+24.85% | 46.71B | |
+48.83% | 41.8B | |
-1.06% | 41.52B | |
-5.86% | 29.55B | |
+10.29% | 25.78B | |
-20.89% | 19.26B | |
+1.84% | 12.14B | |
-3.10% | 12.08B | |
+27.42% | 11.98B |
- Stock Market
- Equities
- ACAD Stock
- News ACADIA Pharmaceuticals Inc.
- Acadia Pharmaceuticals Shares Fall After Late Study of Schizophrenia Drug Fails, Development Ends